Search company, investor...
Search
Biohm Health company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

biohmhealth.com

Stage

Private Equity | Alive

About Biohm Health

Biohm Health develops Biohm, a probiotic engineered to address the role of fungi in gut health. It offers a 360 degree approach to gut health: customers sequence their microbiome with Biohm Gut Report Kit, create a clean slate with Biohm Colon Cleanser, foster an optimized gut environment with Biohm Prebiotic, and obtain total digestive balance with its Biohm Probiotic.

Biohm Health Headquarters Location

737 Bolivar Road

Cleveland, Ohio, 44115,

United States

216-394-0544

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Biohm Health

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Biohm Health is included in 3 Expert Collections, including E-Commerce.

E

E-Commerce

9,755 items

O

Omics

275 items

D

Digital Health

13,114 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

Biohm Health Patents

Biohm Health has filed 3 patents.

The 3 most popular patent topics include:

  • Bacteriology
  • Microbiology
  • Architectural elements
patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/24/2017

9/14/2021

Triangle geometry, Architectural elements, Trigonometry, Elementary geometry, Triangles

Grant

Application Date

10/24/2017

Grant Date

9/14/2021

Title

Related Topics

Triangle geometry, Architectural elements, Trigonometry, Elementary geometry, Triangles

Status

Grant

Latest Biohm Health News

07:02 EDT BIOHM Launches World-Class Suite of Services for Microbiome Leaders, Including Product Development, Bioinformatics, Te...

Aug 31, 2022

News provided by Share this article Share this article Rooted in 50 years of research, the first total microbiome company is unlocking the "Rosetta Stone" of the microbiome for companies and developers looking to optimize gut health and more CLEVELAND, Aug. 31, 2022 /PRNewswire/ -- BIOHM , the leading microbiome company guided by the cutting-edge science of Dr. Mahmoud Ghannoum, is launching a suite of services for microbiome innovators. With established state-of-the-art laboratories and one of the largest microbiome datasets in the world that combines bacterial and fungal sequencing, BIOHM offers turnkey partnership opportunities in ingredient formulation, bioinformatics, testing, and clinical trial support. BIOHM FX under light microscopy showing live active bacterial and fungal cultures. (Photo: BIOHM Health) "Ingredient and product innovation has not utilized the power of microbiome data, even as the tie between the microbiome and human health becomes increasingly clear," said Afif Ghannoum, CEO of BIOHM. "At BIOHM, we felt a responsibility to create access to the most current, comprehensive, and clinically studied microbiome data available. We are excited to work with partners who are truly invested in moving the needle on gut health and overall wellness." The three services offered by BIOHM include: BIOHM offers Microbiome Ingredients and Products, from turnkey ingredients and formulations to cohort selection and postbiotic development. BIOHM is working with global industry leaders to create next generation products that combine bacterial and fungal sequencing with over 50 metadata points. The BIOHM team also created the first data powered probiotic BIOHM FX™ which has been clinically shown to break down digestive biofilms and reduce: bloating, mild constipation, abdominal discomfort, flatulence and improve gut function ratings (GSRS)* White-Label Bioinformatics and Testing is available for partners looking for a turnkey test or a customized bioinformatics pipeline. BIOHM experts will create the appropriate models and mechanisms to achieve established goals, and their proprietary 'plug and play' software portal can provide customized reporting and science-based health solutions from any 16S, ITS and/or metagenomics raw sequencing dataset. Finally, after processing tens of thousands of microbiome tests and supporting numerous clinical trials, BIOHM's scientific team also provides Clinical Trial Support - from design to implementation and testing - so partners can demonstrate proof of concept and/or efficacy. Their expertise in bacteria and fungi provides a robust platform to build scientific understanding that informs new product development. "We never intended to just be another probiotic company when we started BIOHM five years ago," added Sam Schatz. "Dr. Mahmoud Ghannoum was generating ground-breaking research that was being circulated through medical journals - yet not connecting on the consumer level or with OTC products. We wanted to fuel the science that serves other microbiome developers and innovators – with the goal to improve personalized health and wellness on a mass scale. With the launch of these services, we can do that." According to the Washington Post, Dr. Mahmoud Ghannoum is the leading microbiome researcher in the world; he literally named the mycobiome (the body's fungal community) - and he's the frontline tracker on the spreading deadly Candida Auris fungus. Stanford University named Dr. Ghannoum as one of the top 0.5% of cited microbiologists (and top 2% of all scientists across all disciplines) with over 500 papers. His work in the microbiome has been cited over 29,000 times . Dr Ghannoum has been continuously funded by the National Institutes of Health (NIH) since 1991, including just receiving his latest NIH grant at age 72. *In a randomized, placebo-controlled study in 60 healthy adults over 6 weeks, BIOHM FX significantly improved self-reported ratings of gut function, mild bloating and abdominal discomfort compared to placebo (P<0.05). BIOHM FX also improved other measures of gut function within the treatment group after 6 weeks. About BIOHM BIOHM is one of the world's leading microbiome companies utilizing microbiome data to empower individuals to live healthier lives. Our first BIOHM Probiotic supplement was designed to specifically help reduce digestive plaque found in the gut. We have since expanded our line of microbiome data-powered products to include more probiotic and prebiotic supplements, as well as a personalized Gut Test.

Biohm Health Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Biohm Health Rank

  • Where is Biohm Health's headquarters?

    Biohm Health's headquarters is located at 737 Bolivar Road, Cleveland.

  • What is Biohm Health's latest funding round?

    Biohm Health's latest funding round is Private Equity.

  • Who are the investors of Biohm Health?

    Investors of Biohm Health include Vanterra Capital.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.